Skip to main content
Have a personal or library account? Click to login
The problem of low peak concentration of gentamicin in clinical practice Cover

The problem of low peak concentration of gentamicin in clinical practice

European Pharmaceutical Journal
Volume 59 (2012): Issue Supplement-VI (January 2012)
By: ,   and    
Open Access
|Jun 2012
References

References

  1. BERTINO, J., S., Jr. - RODVOLD, K., A., DESTACHE, C., J.: Cost consideration in therapeutic drug monitoring of aminoglycosides. Clin Pharmacokinet, 26, 1, 1994, p. 71 - 81.
    Open DOISearch in Google Scholar
  2. ROBERTS, J., A. - PATERSON, D., L.- MARTIN, J., H.: Therapeutic drug monitoring of antimicrobials. Br J Clin Pharmacol, 73, 1, 2012, p. 27 - 36.
    Open DOISearch in Google Scholar
  3. CONNORS, J., E. - DIPIRO J., T. - SISLEY J., F.: Use of serum concentration in surgical patients. Am J Surg 156, 1, 1988, p. 68 - 76.
    Open DOISearch in Google Scholar
  4. MIGNAVAL, F. - FONTAINE, P., A. - RICHÉ, A. - NOWAK, C. - CANCEL, D. - LEMAITRE, F.: A Priori prediction of gentamicin peak concentrations: Use of a simple and practical tool. PatholBiol (Paris) 59, 2, 2011, p. 79 - 82.
    Open DOISearch in Google Scholar
  5. VARON, J. - MARIK, P.: Management of the Obese Critically Ill Patient. Crit Care Clin 17, 1, 2001, p. 187 - 200.
    Open DOISearch in Google Scholar
  6. ROBERT, S. - ZAROWITZ, B.: Is there a reliable index of glomerular filtration rate in critically ill patients? DICP Ann Pharmacother 25, 2, 1991, p. 169 - 178.
    Open DOISearch in Google Scholar
  7. SAWYER W., T. - CANADAY, B., R. - POE, T., E.: Variables affecting creatinine prediction. Am J Hosp Pharm 40, 12, 1983, p. 2175 - 90.
    Open DOISearch in Google Scholar
  8. EVANS, W., E -OELRICH, M. - HOLTZ, D., W.: Therapeutic Drug Monitoring. Clinical Guide. 2 ed. Wiesbaden, Germany. ABBOTT Laboratory, Diagnostic Division, 1994, 160 p.
    Search in Google Scholar
  9. MURPHY, J., E.: Clinical Pharmacokinetics. 4edition Bethesda, Maryland: American Society Health - System Pharmacists, Publishing, 2008, p. 463.
    Search in Google Scholar
  10. DESOKY, E., E. - KLOTZ, U.: Value, limitations and clinical impact of therapeutic drug monitoring in adults. Drug Invest 6, 3, 1993, p. 127 -136.
    Open DOISearch in Google Scholar
  11. THOMSON, A., H. - DUNCAN, N. - SILVERSTEIN, B. - ALCOCK, S. - JODRELL, D.: Development of guide lines for gentamicin dosing. J Antimicrob Chemother 38, 5, 1996, p.885 - 893.
    Open DOISearch in Google Scholar
  12. GÖBOÖVÁ, M. - MAGULOVÁ, L.: Use of TDM for optimal gentamicin therapy. Acta Chemother 10, 4-5, 2001, p.89 - 93.
    Search in Google Scholar
  13. MAGULOVÁ, L. - VIRÁG, Ľ. - GÖBOÖVÁ, M.: Interpretation of results of therapeutic monitoring levels of gentamicin. (In Slovak). Acta Chemother 16, 5, 2006, p. 49 - 50.
    Search in Google Scholar
  14. ISMAIL, R. - SARRRIFF, A. - ABDUL RAHMAN, A., F.: Therapeutic drug monitoring for gentamicin in Hospital Universiti Sains Malaysia. Med J Malaysia, 45, 1, 1990, p. 57-64.
    Search in Google Scholar
  15. ISMAIL, R. - HAQ, A., H. - RAHMAN, A., F.: Therapeutic drug monitoring of gentamicin: a 6-year follow-up audit. J Clin Ther 22, 1, 2001, p. 21-25.
    Open DOISearch in Google Scholar
  16. LAM, F., Y., W. - Banerji, S. - Hatfield, C. - Talbert, R., L.: Principles of drug administration in renal insufficiency. Clin Pharmacokinetic 32, 1, 1997, p. 30 - 57.
    Open DOISearch in Google Scholar
  17. PAI, M., P. - NAFZIGER, A., N.- BERTINO, J., S.: Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother 55, 9, 2011, p. 4006 - 4011.
    Open DOISearch in Google Scholar
  18. LEYKIN, Y. - MIOTTO, L. - PELLIS, T.: Pharmacokinetic considerations in the obese. Best Pract Res Clin Anaesthesiol 25, 1, 2011, p. 27 -36.
    Open DOISearch in Google Scholar
  19. PAI, M., P.: Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis. 17, 5, 2010, p. 53 - 62.
    Open DOISearch in Google Scholar
  20. SALAZAR, D., E. - CORCORAN, G., B.: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat free body mass. Am J Med 84, 6, 1988, p. 1053 - 1060.
    Open DOISearch in Google Scholar
  21. DHILLON, S. - KOSTRZEWSKI, A.: Clinical Pharmacokinetics. 1edition London, Chicago: Pharmaceutical Press, Publishing, 2006, p. 262.
    Search in Google Scholar
  22. TOD, M., M. - PADOIN, C. - PETITJEAN, O.: Individualising aminoglycosides dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods? Clin Pharmacokinet 40, 11, 2001, p. 803 - 814.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10219-012-0003-y | Journal eISSN: 2453-6725 (formerly 1338-6786) | Journal ISSN: 0301-2298
Journal RSS Feed
Language: English
Page range: 35 - 43
Published on: Jun 19, 2012
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Keywords:
Gentamicin,
Therapeutic Drug Monitoring (TDM),
Peak serum drug concentration
Related subjects:
Pharmacy,
Pharmacy, other

© 2012 M. Göböová, M. Kuželová, T. Foltánová, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons License.

Volume 59 (2012): Issue Supplement-VI (January 2012)
Previous article
Next article